This Is MS Multiple Sclerosis Community: Knowledge & Support

Well, here I am going to talk only about how we get fooled by research on anything but for us specifically CRABS. I've wanted to do this for a long time. I am taking abx, but this is not related so if that's not your thing read on with confidence, it's about trials and how they work. People put huge faith in trials, less in personal experiences. This seems scientific and wise. But do we ...

Hopefully one day in the not-too-distant future they can apply this technology to some of the viruses implicated in MS like EBV and HHV6a.



Supercomputer builds a virus - Vast simulation captures molecules in motion.

Nature - One of the world's most powerful supercomputers has conjured a fleeting moment in the life of a virus. The researchers say the simulation is the first to capture a whole biological organism in such intricate molecular detail.

The ...

Transcript of Friday's NMSS webcast is attached. Ths one is with Dr Steinman and is about discovering better treatments. He mentions a DNA vaccine in trail and another trial of Altered Peptide Ligand (hope I've got the spelling right and that it wasn't the APL trial that was recently pulled). he also mentions FTY720.

On the down side he was asked why different sufferers have different responses to treatments. He said that it can depend ...

I've suffered from headaches since I was a teenager. I used to think they were sinus headaches and always medicated myself accordingly. I had a headache for months after my first MS attack. I finally went to ENT who told me my headaches were from muscle tension. This seems consistent with my other symptoms but I would like to hear from someone else who has MS and headaches. Do you have headaches and if so, ...

Public release date: 16-Mar-2006


Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation

Combining multiple treatments improves multiple sclerosis therapy
Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system (CNS) in which white blood cells known as lymphocytes attack the myelin insulation on nerves in the spinal cord and brain. Glatiramer acetate (GA) is a drug ...

Looks like a good finding.

Thursday is turning out to be a good day so far (in terms of MS news stories).

Ian

New 'stars' in formation of nerve cell insulation 16 March 2006
The insulating myelin sheath enwrapping the cable-like axons of nerve cells is the major target of attack of the immune system in multiple sclerosis. Such attack causes neural short-circuits that give rise to the muscle weakness, loss of coordination, and speech ...

This should go in the stem cell section but I like stories like this.

Note: this is not one of the 'injection of fetal stem cells in Holland story' but a bona fide therapy being trialled in Canada.

Ian

Woman with MS shows remarkable progress in stem cell trial 16 March 2006

A Kanata woman has surpassed all expectations after risking her life to take part in a medical experiment for multiple sclerosis.

In 1996 ...

The transcript of today's NMSS webcast from the NMSS. Today is on genes.

Read through to the end as the final bit is very upbeat.


http://skins.broadbandvideo.com/nmss2/2 ... script.pdf

Another project on genetics / environment and disease was highlighted on the BBC website.

http://news.bbc.co.uk/1/hi/health/4805504.stm

Ian

Six men in intensive care after drug trial
Tue Mar 14, 2006 11:41 PM GMT
Printer Friendly | Email Article | RSS

By Peter Griffiths

LONDON (Reuters) - Six men were seriously ill in a London hospital on Tuesday after taking a new drug during a clinical trial, health officials said.

The volunteers fell ill after taking a drug being developed to treat chronic inflammatory conditions and leukaemia, a medicines watchdog said in a statement. ...

May help in the future - but spare a thought for those poor hamsters.


http://c.moreover.com/click/here.pl?j486818551&w=464753